EuroPCR 2022: Late-breaking Science Video Collection
Published: 13 May 2022
EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx
- EuroPCR 22: AQVA Study Shows Superiority in QFR-Based Virtual PCI Arm
- EuroPCR 22: Patient-Level Pooled Analysis of Ultrasound RDN in radiance-HTN SOLO & Trio
- EuroPCR 22: Optimize PRO Interim Analysis Finds New Technique is "Best-in-Class"
- EuroPCR 22: MASTER-DAPT Sub-Analysis Shows Consistent Results in Complex PCI Patients
- EuroPCR 22: CRUZ-HBR Indicates Use Of Supraflux™ Cruz Stent Is Favourable
- EuroPCR 22: ASTRO-TAVI Shows Improved Neurological Outcomes With Neurointervention
- EuroPCR 22: Short-Term Clinical Outcomes of ACURATE neo2™
- EuroPCR 22: DECISION QFR Shows Increased Practicability and Shorter Procedure Time for Revasc.
- EuroPCR 22: SYNERGY™ Non-inferior to BioMatrix NeoFlex in OCT SORT-OUT VIII
- EuroPCR 22: ROLEX Study Finds Promising Results in CAD Pts With the Resolute Onyx
- EuroPCR 22: Balloon Vs Self-Expanding Valves in Valve-in-Valve TAVI
- EuroPCR 22: MitraClip in Atrial Functional Mitral Regurgitation
- EuroPCR 22: SCB with Micro-Reservoir Technology in Coronary Lesions
- EuroPCR 22: FORWARD PRO Study Shows No Durability Issues After 3 Years
- EuroPCR 22: DEB & DES in the Treatment of Diffuse CAD
- EuroPCR 22: EASTBOURNE Registry indicates Satefy of Sirolimus-Coated Balloon
- EuroPCR 22: JenaValve TAVR System for the Treatment of Aortic Regurgitation
- EuroPCR 22: Transcatheter Tricuspid Valve Repair with PASCAL System
- EuroPCR 2022: ALIGN-EFS Finds 100% Procedural Success Rate Using JenaValve Trilogy in Pts With AS
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science trials and spotlight questions that could change treatment strategies in interventional cardiology.
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
View from the Thoraxcenter
Prof Giuseppe Tarantini serves as Head of the Interventional Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua (Italy) and in an internationally renowned researcher in the fields of ischemic heart disease, structural heart disease and cardiomyopathies.
He acts as first operator for a wide range of interventional procedures including Coronary interventions (including atherectomies), Peripheral interventions (Carotid and Renal) and Structural Heart interventions (ASDs, PFOs, TAVI and AVP).
Prof Tarantini is a faculty member of a number of international conferences including Transcatheter Cardiovascular Therapeutics (TCT), Congresso della Societa Italiana di Cardiologia Invasiva (SICI-GISE), Euro PCR and European Society of Cardiology (ESC). He has published 245 clinical papers and serves as an editorial board member and reviewer for a number of respected journals.